Cost-effectiveness of tezepelumab in Canada for severe asthma.
Habash M, Guiang H, Mayers I, Quinton A, Vuong V, Dineen A, Singh S, Gibson D, Turner AP.
Habash M, et al. Among authors: guiang h.
J Med Econ. 2023 Jan-Dec;26(1):902-914. doi: 10.1080/13696998.2023.2234235.
J Med Econ. 2023.
PMID: 37417781
Free article.